The Drug-Drug Interactions Ontology

Last uploaded: February 11, 2016

Id	http://purl.obolibrary.org/obo/CHEBI_65347 http://purl.obolibrary.org/obo/CHEBI_65347
Preferred Name	carfilzomib
Synonyms	(2S)-4-methyl-N-[(1S)-1-{[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]carbamoyl}-2-phenylethyl]-2-[(2S)-2-[2-(morpholin-4-yl)acetamido]-4-phenylbutanamido]pentanamide Kyprolis C40H57N5O7 N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}-L-phenylalaninamide carfilzomib
Type	http://www.w3.org/2002/07/owl#Class

prefLabel	carfilzomib
label	carfilzomib
DBSynonym	pr-171
ATCCode	L01XX45
Definition	Carfilzomib is an injectable antineoplastic agent (IV only). Chemically, it is a modified tetrapeptidyl epoxide and an analog of epoxomicin. It is also a selective proteasome inhibitor. FDA approved on July 20, 2012. A synthetic tetrapeptide consisting of morpholin-4-acetyl, L-2-amino-4-phenylbutanoyl, L-leucyl and L-phenylalanyl residues joined in sequence with the C-terminus connected to the amino group of (2S)-2-amino-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-1-one via an amide linkage. Used for the treatment of patients with multiple myeloma
has pharmacological target	http://purl.obolibrary.org/obo/dinto_2938 http://purl.obolibrary.org/obo/dinto_1816 http://purl.obolibrary.org/obo/dinto_1819 http://purl.obolibrary.org/obo/dinto_3068 http://purl.obolibrary.org/obo/dinto_3066 http://purl.obolibrary.org/obo/dinto_1758 See more See less
inhibits	http://purl.obolibrary.org/obo/dinto_2938 http://purl.obolibrary.org/obo/dinto_1816 http://purl.obolibrary.org/obo/dinto_1819 http://purl.obolibrary.org/obo/dinto_3068 http://purl.obolibrary.org/obo/dinto_3066 http://purl.obolibrary.org/obo/dinto_1758 See more See less
type	http://www.w3.org/2002/07/owl#Class
has role	http://purl.obolibrary.org/obo/CHEBI_35610 http://purl.obolibrary.org/obo/CHEBI_52726
InChIKey	InChIKey=BLMPQMFVWMYDKT-NZTKNTHTSA-N
AHFScode	10:00
Synonym	(2S)-4-methyl-N-[(1S)-1-{[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]carbamoyl}-2-phenylethyl]-2-[(2S)-2-[2-(morpholin-4-yl)acetamido]-4-phenylbutanamido]pentanamide Kyprolis C40H57N5O7 N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}-L-phenylalaninamide carfilzomib
xref	ChEMBL:620664 CiteXplore:22734651 Wikipedia:http://en.wikipedia.org/wiki/Carfilzomib ChEBI:65347 Reaxys:12488950 CiteXplore:19348473 CiteXplore:20937826 CiteXplore:22507794 CiteXplore:22761464 CiteXplore:21905015 RxList:http://www.rxlist.com/kyprolis-drug.htm CiteXplore:22235146 CiteXplore:22645181 CiteXplore:22621161 Wikipedia:Carfilzomib Drugs.com:http://www.drugs.com/kyprolis.html CiteXplore:22411899 National Drug Code Directory:76075-101-01 CiteXplore:22507799 CiteXplore:22665938 CASRN:868540-17-4 CiteXplore:22727391 CiteXplore:22726549 CiteXplore:22763387 KEGG DRUG:D08880 CiteXplore:22555973 See more See less
CASRN	868540-17-4
prefixIRI	obo2:CHEBI_65347
is transported by	http://purl.obolibrary.org/obo/dinto_1440
SMILES	CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1 CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1
InChI	InChI=1S/C40H57N5O7/c1-27(2)22-32(36(47)40(5)26-52-40)42-39(50)34(24-30-14-10-7-11-15-30)44-38(49)33(23-28(3)4)43-37(48)31(17-16-29-12-8-6-9-13-29)41-35(46)25-45-18-20-51-21-19-45/h6-15,27-28,31-34H,16-26H2,1-5H3,(H,41,46)(H,42,50)(H,43,48)(H,44,49)/t31-,32-,33-,34-,40+/m0/s1
DBBrand	kyprolis
subClassOf	http://purl.obolibrary.org/obo/dinto_000055

Add comment

Add proposal

Subscribe to notes emails

Delete	Subject	Author	Type	Created
No notes to display